NCT04060654 2025-03-25SUBLOCADE Rapid Initiation Extension StudyIndivior Inc.Phase 4 Completed17 enrolled 12 charts
NCT02611752 2019-11-14A Multiple Dose Opioid Challenge StudyBraeburn PharmaceuticalsPhase 2 Completed47 enrolled 18 charts